# Enhanced synthesis of 1, 3-medium chain-2-long chain triacylglycerols by engineered Saccharomyces cerevisiae

**Authors:** Zhuangju Peng, Zikun Zhang, Rihan Gao, Li Deng, Fang Wang, Junfeng Liu

PMC · DOI: 10.1186/s40643-026-01023-6 · Bioresources and Bioprocessing · 2026-02-28

## TL;DR

This paper describes a new method to produce a specific type of fat using engineered yeast, which could be more cost-effective than current methods.

## Contribution

The study introduces an engineered yeast strain that efficiently produces MLM-TAGs through iterative genetic and environmental optimizations.

## Key findings

- Overexpression of fas1R1834K increased medium-chain fatty acid production to 0.41 mol% of total TAGs.
- Introduction of RnACSM4 and deletion of GAT2 and LRO1 raised MLM-TAGs to 6.7 mol%.
- Optimized conditions achieved 34.4 mol% MLM-TAGs with a 135-fold yield improvement over the original strain.

## Abstract

Enzymatic synthesis is currently the primary method for preparing 1,3-medium chain- 2-long-chain triacylglycerols (MLM-TAGs), which serve as both a dietary component and clinical nutrient for specific populations. The application of MLM-TAGs is obviously constrained by the high cost of catalysts. Hence, a novel approach was proposed for MLM-TAGs production by engineered yeast. Overexpressing the mutated fas1R1834K increased the production of medium-chain fatty acids (C8–C12) and resulted in an MLM content of 0.41 mol% of the total TAGs. The introduction of RnACSM4 enabled the recombinant to produce MLM-TAGs at a level of 4.2 mol% when supplemented with 0.2 mM sodium laurate. Further deletion of GAT2 and LRO1 increased the content of MLM-TAGs to 6.7 mol%. Iterative optimization involving sodium laurate dosage, culture temperature, and amino acid addition elevated the MLM-TAGs content to 34.4 mol%. Under the optimized conditions, the maximum yield of MLM-TAGs reached 18.5 mg/g DCW, representing a 135-fold improvement over the original strain. This research presents a promising and sustainable alternative for MLM-TAGs production and demonstrates the feasibility of tailoring the acyl composition of intracellular TAGs.

The online version contains supplementary material available at 10.1186/s40643-026-01023-6.

## Linked entities

- **Genes:** SLC6A12 (solute carrier family 6 member 12) [NCBI Gene 6539], lro-1 (Lysosome-Related Organelle protein) [NCBI Gene 180901]
- **Chemicals:** sodium laurate (PubChem CID 2735067)
- **Species:** Saccharomyces cerevisiae (taxon 4932)

## Full-text entities

- **Genes:** GAT2 (Gat2p) [NCBI Gene 855167], Acsm4 (acyl-CoA synthetase medium-chain family member 4) [NCBI Gene 353317] {aka Omacs}, Slc6a1 (solute carrier family 6 member 1) [NCBI Gene 79212] {aka Gabt1, Gat1}, ALE1 (lysophospholipid acyltransferase) [NCBI Gene 854346] {aka LCA1, LPT1, SLC4}, FAS1 (tetrafunctional fatty acid synthase subunit FAS1) [NCBI Gene 853653], TRP1 (phosphoribosylanthranilate isomerase TRP1) [NCBI Gene 851570], Mchr1 (melanin-concentrating hormone receptor 1) [NCBI Gene 83567] {aka Gpr24, Mch-1r, Slc1}, Slc6a13 (solute carrier family 6 member 13) [NCBI Gene 171163] {aka GAT-2}, HIS4 (trifunctional histidinol dehydrogenase/phosphoribosyl-AMP cyclohydrolase/phosphoribosyl-ATP diphosphatase) [NCBI Gene 850327], Dgat1 (diacylglycerol O-acyltransferase 1) [NCBI Gene 84497] {aka ARAT, Dgat}, URA3 (orotidine-5'-phosphate decarboxylase) [NCBI Gene 856692], LEU2 (3-isopropylmalate dehydrogenase) [NCBI Gene 850342], LRO1 (phospholipid:diacylglycerol acyltransferase) [NCBI Gene 855742], SLC1 (1-acylglycerol-3-phosphate O-acyltransferase SLC1) [NCBI Gene 851508]
- **Diseases:** cytotoxicity (MESH:D064420), MLM (MESH:C536038)
- **Chemicals:** agar (MESH:D000362), TAG (MESH:D014280), esters (MESH:D004952), lithium acetate (MESH:C488804), uracil (MESH:D014498), nitrogen (MESH:D009584), histidine (MESH:D006639), NH4Cl (MESH:D000643), n-hexane (MESH:C026385), sugar (MESH:D000073893), methanol (MESH:D000432), SC (MESH:D012538), C12:0 (MESH:C030358), HCl (MESH:D006851), glutamate (MESH:D018698), acetic acid (MESH:D019342), C18:0 (MESH:C031183), water (MESH:D014867), tyrosine (MESH:D014443), Leu (MESH:D007930), palmitoyl-CoA (MESH:D010171), Glycerol-3-phosphate (MESH:C029620), serine (MESH:D012694), arginine (MESH:D001120), Fatty acid (MESH:D005227), monounsaturated fatty acids (MESH:D005229), acyl-CoA (MESH:D000214), Amino acids (MESH:D000596), silica (MESH:D012822), polyunsaturated fatty acids (MESH:D005231), glycerol (MESH:D005990), C8:0 (MESH:C031492), 1, 3-dioleoyl-2-palmitoyl (OPO) triacylglycerol (-), ether (MESH:D004986), Glucose (MESH:D005947), sulfuric acid (MESH:C033158), monoglyceride (MESH:D050178), lysine (MESH:D008239), Lipids (MESH:D008055), cysteine (MESH:D003545), chloroform (MESH:D002725), (NH4)2SO4 (MESH:D000645), KOH (MESH:C029943)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** Arg1834Lys
- **Cell lines:** YS58 — Rattus norvegicus (Rat), Rat sarcoma, Cancer cell line (CVCL_4U54)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950145/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950145/full.md

---
Source: https://tomesphere.com/paper/PMC12950145